February 27, 2018
Via: ForbesThe firm, Quentis Therapeutics, says that the money will fund clinical trials for its new medicine, a small molecule IRE1α inhibitor, to begin next year. The idea is that harsh conditions within tumors inhibit the immune system from attacking the […]
January 12, 2023
January 26, 2023
January 27, 2023
January 31, 2023
January 31, 2023
January 26, 2023